View Older Stories View More Recent Stories

Jul 30, 2019 07:45AM BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
Jul 30, 2019 07:45AM BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
Jul 9, 2019 08:00AM BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
Jul 9, 2019 08:00AM BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
May 6, 2019 04:05PM BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations
May 6, 2019 04:05PM BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations
Apr 25, 2019 04:30PM BioDelivery Sciences to Report First Quarter 2019 Financial Results
Apr 25, 2019 04:30PM BioDelivery Sciences to Report First Quarter 2019 Financial Results
Apr 10, 2019 04:35PM Shionogi Announces Licensing of Symproic® (naldemedine) to BioDelivery Sciences International Inc.
Apr 10, 2019 04:06PM BioDelivery Sciences (BDSI) Acquires U.S. Commercial Rights to Symproic
Apr 10, 2019 04:06PM BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Apr 10, 2019 04:06PM BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Mar 14, 2019 04:05PM BioDelivery Sciences Reports Strong 2018 Results and 2019 Expectations
Feb 21, 2019 07:45AM BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
Feb 21, 2019 07:45AM BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
Feb 4, 2019 08:13AM BioDelivery Sciences (BDSI) Reports Expanded Preferred Insurance Coverage For BELBUCA
Feb 4, 2019 08:03AM BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®
Feb 4, 2019 08:03AM BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®
Nov 8, 2018 04:05PM BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
Nov 8, 2018 04:05PM BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
Aug 7, 2018 08:30AM EyeGate Pharmaceuticals Announces New Board Member, Peter Greenleaf
Aug 7, 2018 08:30AM EyeGate Pharmaceuticals Announces New Board Member, Peter Greenleaf
May 10, 2018 04:01PM BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update
Apr 30, 2018 07:00AM BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2018 Financial Results on Thursday, May 10
Jan 4, 2018 08:00AM Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development
Dec 18, 2017 09:28AM Pre-Open Movers 12/18: (BETR) (TYHT) (AKAM) Higher; (ERII) (PETX) (CSX) Lower (more...)
Nov 16, 2017 07:00AM BioDelivery Sciences to Present at the 29th Annual Piper Jaffray Conference
Nov 9, 2017 04:01PM BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Oct 30, 2017 07:00AM BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9
Oct 6, 2017 07:00AM BioDelivery Sciences Participates in U.S. Department of Health and Human Services Round Table Discussion on Pain Management and Opioid Dependence
Sep 19, 2017 07:00AM BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference
Sep 12, 2017 08:03AM BioDelivery Sciences (BDSI) Secures Market Authorization Transfer by Health Canada for BELBUCA and Associated Milestone Payment
Sep 12, 2017 08:00AM BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment
Sep 7, 2017 08:00AM BioDelivery Sciences Presents Data on BELBUCA® (buprenorphine) Buccal Film at the PAINWeek 2017 Conference
Aug 24, 2017 07:30AM BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Aug 23, 2017 07:31AM BioDelivery Sciences (BDSI) CEO Dr. Mark A. Sirgo to Retire, Continue as Vice Chairman
Aug 23, 2017 07:30AM BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
Aug 17, 2017 07:00AM BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017
Aug 9, 2017 04:01PM BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Jul 28, 2017 07:00AM BioDelivery Sciences to Host Conference Call and Webcast Reporting
Jun 23, 2017 07:01AM BioDelivery Sciences (BDSI) BELBUCA Approved by Health Canada
Jun 23, 2017 07:00AM BioDelivery Sciences Announces Health Canada Approval of BELBUCA®
Jun 21, 2017 08:49AM BioDelivery Sciences (BDSI) Announces Agreement with CVS/Caremark for BELBUCA and BUNAVAIL Through 2020
Jun 21, 2017 08:48AM BioDelivery Sciences Announces Agreement with CVS/Caremark for BELBUCA® and BUNAVAIL® Through 2020
Jun 1, 2017 07:49AM BioDelivery Sciences to Present at the Jefferies 2017 Healthcare Conference and the William Blair 2017 Growth Stock Conference
May 15, 2017 04:01PM BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 15, 2017 04:01PM /C O R R E C T I O N -- BioDelivery Sciences International, Inc./
May 9, 2017 09:23AM BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial Results on Monday, May 15
May 2, 2017 07:14AM BioDelivery Sciences (BDSI) Announces FDA Approval of BUNAVAIL for Induction of Buprenorphine Treatment for Opioid Dependence
May 2, 2017 07:00AM BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment for Opioid Dependence
View More Recent Stories View Older Stories